A postdoctoral research position is available in Division of Pharmaceutics & Pharmacology at the Ohio State University to conduct research in the understanding of solute carrier (SLC) membrane transporters. The candidate is expected to have a strong background in at least one of the following areas: biochemistry, molecular biology, cell biology, or immunology, and to be interested in studying the link between SLCs, disease pathogenesis, and treatment as it relates to cancer, HIV, and/or genetic disorders.
Facilitative lysosomal transport of bile acids alleviates ER stress in mouse hematopoietic precursors. Persaud et al. Nat Commun. 2021 Feb 23;12(1):1248.
EMT-Induced Gemcitabine Resistance in Pancreatic Cancer Involves the Functional Loss of Equilibrative Nucleoside Transporter 1.
Weadick et al. Mol Cancer Ther. 2021 Feb;20(2):410-422.
A kinome-wide screen identifies a CDKL5-SOX9 regulatory axis in epithelial cell death and kidney injury.
Kim et al. Nat Commun. 2020 Apr 21;11(1):1924.
Adult stem cell deficits drive Slc29a3 disorders in mice.
Nair et al. Nat Commun. 2019 Jul 3;10(1):2943.
Applicants should contact Dr. Raj Govindarajan (firstname.lastname@example.org) and submit their CV. Address: 460 W 12th Ave, Columbus, OH 43210